GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » 10x Genomics Inc (MEX:TXG) » Definitions » EV-to-FCF

10x Genomics (MEX:TXG) EV-to-FCF : 69.62 (As of Oct. 31, 2024)


View and export this data going back to 2021. Start your Free Trial

What is 10x Genomics EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, 10x Genomics's Enterprise Value is MXN33,781 Mil. 10x Genomics's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was MXN485 Mil. Therefore, 10x Genomics's EV-to-FCF for today is 69.62.

The historical rank and industry rank for 10x Genomics's EV-to-FCF or its related term are showing as below:

MEX:TXG' s EV-to-FCF Range Over the Past 10 Years
Min: -1143.22   Med: -64.23   Max: 84.05
Current: 67.29

During the past 7 years, the highest EV-to-FCF of 10x Genomics was 84.05. The lowest was -1143.22. And the median was -64.23.

MEX:TXG's EV-to-FCF is ranked worse than
85.24% of 393 companies
in the Healthcare Providers & Services industry
Industry Median: 19.48 vs MEX:TXG: 67.29

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-10-31), 10x Genomics's stock price is MXN440.00. 10x Genomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was MXN-27.135. Therefore, 10x Genomics's PE Ratio (TTM) for today is At Loss.


10x Genomics EV-to-FCF Historical Data

The historical data trend for 10x Genomics's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10x Genomics EV-to-FCF Chart

10x Genomics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial -853.07 -57.59 -132.53 -23.37 -98.44

10x Genomics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -40.85 -98.44 -56.97 -61.37 96.67

Competitive Comparison of 10x Genomics's EV-to-FCF

For the Health Information Services subindustry, 10x Genomics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


10x Genomics's EV-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where 10x Genomics's EV-to-FCF falls into.



10x Genomics EV-to-FCF Calculation

10x Genomics's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=33781.468/485.215
=69.62

10x Genomics's current Enterprise Value is MXN33,781 Mil.
10x Genomics's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN485 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


10x Genomics  (MEX:TXG) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

10x Genomics's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=440.00/-27.135
=At Loss

10x Genomics's share price for today is MXN440.00.
10x Genomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-27.135.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


10x Genomics EV-to-FCF Related Terms

Thank you for viewing the detailed overview of 10x Genomics's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


10x Genomics Business Description

Traded in Other Exchanges
Address
6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.